"It's a great meeting. I wouldn't miss it. It's the only meeting that focuses solely on employee health."
— Rick Finch, Drummond
"I was really happy to meet with all these delegates on a 1 to 1 basis. Very intimate."
— Tom Cleppe, President, Valezon, Inc.
|
|
|
|
|
Wednesday, February 3, 2010
|
1:45 pm -
2:40 pm
|
|
2:45 pm -
3:40 pm
|
| The session provides an overview on "Over the Counter" treatment options available, the overlap with many formulary treatments, and ways to manage the formulary and cost to maximize employee value and minimize cost. |
|
Lynn Zonakis, BA, BSN, RN
Managing Director, Health Strategy and Resources
Delta Air Lines
 View Biography
|
|
|
|
|
Thursday, February 4, 2010
|
1:25 pm -
2:20 pm
|
|
2:25 pm -
3:20 pm
|
- Comprehensive clinical review from specialists
- Benchmarking against "best-in-class" treatment options
- Investing in quality improvements to reduce long-term healthcare costs
- Duration of data exclusivity on biosimilars
|
|
Speaker TBA
|
|
|
|
3:20 pm -
3:50 pm
|
|
3:50 pm -
4:45 pm
|
- Specialty drug coverage
- Compliance and adherence
|
|
|
|
|
|
|
|
|
Printer Friendly
Email A Colleague
Bookmark Page
